MDXH

MDxHealth S.A. (MDXH) Scenario Analysis Analysis (2026)

Invetso Score: 2.6/10 — Weak · Last Updated: 2026-09-01

Overall Score

Base Case

TTM revenue multiple is low at 1.26x EV/Sales, but profitability remains negative with EBIT margin at -15.9% and net margin at -32.2%.

Liquidity is only modest with a current ratio of 1.08 and quick ratio of 0.94, while leverage remains elevated relative to market cap.

Bull Case

Gross margin is still healthy at 57.7%, leaving room for operating leverage if cost discipline improves.

Free cash flow generation is positive on a firm basis, but conversion is weak and earnings quality remains very low at 0.04.

Bear Case

Sustained losses and negative operating cash flow keep downside risk high if revenue growth stalls.

Interest coverage is negative at -0.92x and debt-to-capital is above 1.0x, increasing refinancing and solvency risk.

Working capital is positive, but the cash conversion cycle remains extended at 27.8 days.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on MDxHealth S.A.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →